test

Mark Gottlieb

@Altium Capital Management Lp

Latest period2024 - Q3ReportedManaged Assets$339.708MTotal holdings77
Assets growth rate-99.86%Assets growth rate (2-Q avg)-51.42%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Altium Capital Management Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 77 positions.

Assets under management

The assets under management (AUM) of Altium Capital Management Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 339.708M in assets, with a quarterly growth rate of -99.86% and a 2-quarter average growth rate of -51.42%. The portfolio is managed by Mark Gottlieb, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
KROSKeros Therapeutics Inc
Recent Activity
New Position
1.18%
$4.007M
69,000 shares@ $58.07 avg price
REALThe Realreal Inc
Recent Activity
Increased 1.59%
1.18%
$3.988M
1.27M shares@ $3.14 avg price
CATXPerspective Therapeutics Inc
Recent Activity
Increased 51.48%
1.14%
$3.871M
290,000 shares@ $13.35 avg price
BHVNBiohaven Ltd
Recent Activity
New Position
1.11%
$3.748M
75,000 shares@ $49.97 avg price
ORICOric Pharmaceuticals Inc
Recent Activity
Decreased -12.34%
1.08%
$3.639M
355,000 shares@ $10.25 avg price
GPCRStructure Therapeutics Inc
Recent Activity
New Position
0.91%
$3.072M
70,000 shares@ $43.89 avg price
OTLKOutlook Therapeutics Inc
Recent Activity
Increased 7.93%
0.86%
$2.892M
541,549 shares@ $5.35 avg price
VCELVericel Corp
Recent Activity
New Position
0.85%
$2.873M
68,000 shares@ $42.25 avg price
CYBNCybin Inc
Recent Activity
New Position
0.83%
$2.818M
317,000 shares@ $8.89 avg price
TERNTerns Pharmaceuticals Inc
Recent Activity
New Position
0.82%
$2.752M
330,000 shares@ $8.34 avg price